Date: Thu, 18 Dec 1997 14:52:18 GMT Server: Stronghold/1.3.4 Ben-SSL/1.3 Apache/1.1.3 Content-type: text/html Content-length: 16708 Last-modified: Mon, 06 Oct 1997 14:22:09 GMT Corporate
Picture

Scientific Advisory Board

Michael A. Chirigos, Ph.D., D.Sc.

Former Chief, Laboratory of Immunopharmacology,

Division of Cancer Treatment, National Cancer Institute, N.I.H.;

Deputy of Science, United States Army

Medical Research Institute of Infectious Diseases.

Evan M. Hersh, M.D.

Vice-Chairman, Department of Internal Medicine;

Chief, Section of Hematology and Oncology,

Department of Internal Medicine;

Director of Clinical Research,

Arizona Cancer Center,  Tucson, Arizona.

Michael J. Mastrangelo, M.D.

Director, Division of Medical Oncology,

Jefferson Medical College, Philadelphia, PA.;

Professor of Medicine,

Jefferson Medical College, Philadelphia, PA.;

Associate Clinical Director,

Jefferson Cancer Center, Philadelphia, PA.

Alan G. Morris, Ph.D.

Department of Biological Sciences,

University of Warwick, Coventry, UK.

Board of Directors

Maximilian de Clara

Chairman and President

CEL-SCI Corporation

Geert R. Kersten

Chief Executive Officer

CEL-SCI Corporation

F. Donald Hudson

Biotechnology Consultant

Founder of Several Biotechnology Companies

Mark V. Soresi

President

REMAC USA. Inc.

Corporate Officers

Maximilian de Clara

Chairman of the Board

President

Geert R. Kersten

Chief Executive Officer

Treasurer and Secretary

Patricia B. Prichep

Vice President of Operations

Prem Sarin, Ph.D.

Vice President of Research,

Infectious Diseases

Eyal Talor, Ph.D.

Vice President of Research and Manufacturing

M. Douglas Winship

Vice President of Regulatory Affairs and Quality Assurance

Daniel Zimmerman, Ph. D.

Vice President of Research, Cellular Immunology

Corporate Information

Corporate Headquarters

CEL-SCI Corporation

66 Canal Center Plaza, Suite 510

Alexandria, Virginia 22314 USA

Telephone: 703-549-5293

Facsimile: 703-549-6269

WWW: http://www.cel-sci.com

Certified Public Accountants

Deloitte & Touche

Washington, D.C.

Counsel

Hart & Trinen

Denver, Colorado

Transfer Agent and Registrar

American Securities Transfer & Trust, Inc.

938 Quail Street, Suite 101

Lakewood, Colorado 80215

Telephone: 303-234-5300

Stockholders Inquiries

Inquiries regarding transfer requirements, lost certificates and change of address should be directed to the transfer agent.

Stock Profile

CEL-SCI Corporation’s Common Stock and Warrants are traded on the American Stock Exchange under the symbols HIV and HIV WS respectively.

There are approximately 3,000 stockholders of record as of September 30, 1996. The Company has not paid cash dividends on its Common Stock since its inception.

SEC Form 10-K

A copy of the Company's annual report to the Securities and Exchange Commission on Form 10-K is available without charge upon written request to:

Corporate Communications, CEL-SCI Corporation

66 Canal Center Plaza, Suite 510

Alexandria VA 22314 USA

 

66 Canal Center Plaza Suite 510
 Alexandria VA 22314
 USA
 Telephone: 703-549-5293
 Facsimile:  703-549-6269

Home  Publications   Mission   Shareholder Letter   Product Chart    Basics    Questions    Corporate    FY96     Employment

site designed and hosted by everettcd.com

 Home

66 Canal Center Plaza Suite 510
 Alexandria VA 22314
 USA
 Telephone: 703-549-5293
 Facsimile:  703-549-6269

site designed and hosted by everettcd.com